Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sanofi-Aventis |
---|---|
Information provided by: | Sanofi-Aventis |
ClinicalTrials.gov Identifier: | NCT00705276 |
To prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Femina Delicata.
Condition | Intervention | Phase |
---|---|---|
Hygiene |
Drug: Lactic acid (Dermacyd Femina Delicata) |
Phase III |
Study Type: | Interventional |
Study Design: | Supportive Care, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Femina Delicata |
Enrollment: | 26 |
Study Start Date: | April 2008 |
Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
I: Experimental | Drug: Lactic acid (Dermacyd Femina Delicata) |
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Responsible Party: | sanofi-aventis ( Medical Affairs Study Director ) |
Study ID Numbers: | LACAC_L_03983 |
Study First Received: | June 25, 2008 |
Last Updated: | June 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00705276 |
Health Authority: | Brazil: National Health Surveillance Agency |